New safety test aims to unlock Life-Improving drug for type 1 diabetes
Disease control
Not yet recruiting
This study aims to make a promising diabetes drug safer for people with type 1 diabetes. The drug, Dapagliflozin, helps control blood sugar and weight but carries a risk of a dangerous condition called diabetic ketoacidosis (DKA). Researchers are testing if using a continuous ket…
Phase: PHASE2 • Sponsor: St Vincent's Hospital Melbourne • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC